<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Pharmaceutical sciences / Research / Drug development / Clinical trial / William K. Oh / Richmond Pharmacology Ltd / Medicine / Pharmacology / Drug discovery
Date: 2014-06-30 21:58:23
Pharmaceutical industry
Pharmaceutical sciences
Research
Drug development
Clinical trial
William K. Oh
Richmond Pharmacology Ltd
Medicine
Pharmacology
Drug discovery

Microsoft Word - IDSC_Pubs_Listing_5[removed]doc

Add to Reading List

Source URL: www.cancer.gov

Download Document from Source Website

File Size: 12,69 KB

Share Document on Facebook

Similar Documents

· Prostate Cancer · Is Docetaxel Chemotherapy a New Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer? Bobby C. Liaw, MD, and William K. Oh, MD

DocID: 1m55m - View Document

Biomarkers / Prostate-specific antigen / Urology / Prostate cancer / Prostate cancer screening / William K. Oh / Medicine / Tumor markers / Andrology

BVKC - SBCC Belgian Society for Clinical Chemistry Dear visitor This is one of the presentations of the 2007 symposium of

DocID: 18DOw - View Document

Urologists / Prostate cancer / Urology / Clinical Genitourinary Cancer / William K. Oh / Medicine / Oncologists / Surgeons

12-14 JULY 2015 SOFITEL SYDNEY WENTWORTH ANZUP ANNUAL SCIENTIFIC MEETING Redefining Personalised Medicine  #ANZUP15

DocID: 18gyj - View Document

Prostate cancer screening / Prostate cancer / Prostate-specific antigen / PCA3 / Prostate biopsy / Prostate / Screening / EDRN / William K. Oh / Medicine / Tumor markers / Cancer screening

New Blood and Urine Tests to Improve Detection of Aggressive Prostate Cancer: Progress from the NCI Early Detection Research Network Martin G. Sanda, MD Professor and Chairman of Urology Emory University School of Medici

DocID: 17Tom - View Document

Prostate cancer / Cancer research / Cancer / Prostate / Prostate Cancer Foundation / William K. Oh / Medicine / Oncology / Cancer organizations

PDF Document

DocID: 17rRN - View Document